In pursuit of the prevention of breast cancer.
Yardley
D A
DA
University of Texas Southwestern Medical Center, Dallas 75390-8852, USA. yardley@simmons.swmed.edu
D000367:Age Factors; D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D015331:Cohort Studies; D015986:Confounding Factors, Epidemiologic; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D004195:Disease Models, Animal; D004641:Emigration and Immigration; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D007558:Italy; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use; D018433:Twin Studies as Topic; D006113:United Kingdom
D016588:Anticarcinogenic Agents; D003278:Contraceptives, Oral, Hormonal; D020847:Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride